Extrapulmonary tuberculosis - Causes, Treatment & When to See a Doctor

```html

What is Extrapulmonary Tuberculosis?

Extrapulmonary tuberculosis (EPTB) is a form of tuberculosis (TB) that occurs when the bacterium Mycobacterium tuberculosis spreads outside the lungs and infects other organs or tissues. While pulmonary TB (infection of the lungs) is the most common presentation, up to 20 % of TB cases in immunocompetent adults and up to 50 % in people living with HIV involve extrapulmonary sites.<sup>1</sup> The disease can affect lymph nodes, the pleura, the central nervous system, the bones and joints, the genitourinary system, the gastrointestinal tract, and many other locations. Because the signs and symptoms depend on the organ involved, EPTB is often more difficult to recognize than pulmonary TB.

Common Causes

EPTB does not have separate “causes” in the traditional sense; it results from the same bacterium that causes pulmonary TB. However, certain conditions increase the likelihood that TB will disseminate beyond the lungs. The most important risk factors and co‑existing conditions include:

• Human immunodeficiency virus (HIV) infection – severe immunosuppression impairs the body’s ability to contain the bacilli.
• Other immunosuppressive diseases – such as diabetes mellitus, chronic kidney disease, or malignancy.
• Use of immunosuppressive drugs – corticosteroids, tumor‑necrosis‑factor (TNF) inhibitors, and other biologics.
• Malnutrition – protein‑energy deficiency reduces cell‑mediated immunity.
• Young age – children have immature immune systems and are more prone to disseminated disease.
• Recent organ transplantation – requires lifelong immunosuppression.
• Silicosis or other occupational lung diseases – impair local lung defenses, facilitating spread.
• Previous treatment for TB – especially if treatment was incomplete, leading to resistant strains.
• Geographic exposure – living in or traveling to regions with high TB prevalence (e.g., sub‑Saharan Africa, South‑East Asia, parts of Eastern Europe).
• Genetic susceptibility – certain HLA types and innate immune defects have been linked to a higher risk of EPTB.

Associated Symptoms

The clinical picture varies widely because symptoms reflect the organ involved. Below are the most frequently reported manifestations, grouped by common sites of infection:

Lymphatic (most common EPTB site)

• Painless, firm swelling of cervical, supraclavicular, or axillary lymph nodes.
• Gradual enlargement over weeks to months; nodes may become matted.
• Occasional low‑grade fever, night sweats, and weight loss.

Pleural (involving the lining of the lungs)

• Sharp chest pain that worsens with deep breathing.
• Shortness of breath and a dry cough.
• Fever and pleural effusion detectable on chest X‑ray.

Central Nervous System (meningitis, tuberculoma, spinal TB)

• Persistent headache, neck stiffness, photophobia.
• Altered mental status, seizures, or focal neurological deficits.
• Back pain with possible spinal deformity (Pott disease).

Bone & Joint (skeletal TB)

• Chronic pain and swelling in a joint (commonly the hip or knee).
• Reduced range of motion; may mimic osteoarthritis.
• Systemic symptoms such as low‑grade fever.

Genitourinary (kidney, prostate, or reproductive tract)

• Flank pain, hematuria, or recurrent urinary tract infections.
• Painful ejaculation or decreased fertility in men.
• Pelvic pain and menstrual irregularities in women.

Gastrointestinal & Peritoneal

• Abdominal pain, especially in the right iliac fossa.
• Chronically watery or bloody diarrhea.
• Ascites (fluid accumulation) and weight loss.

Systemic “B‑symptoms”—fever, night sweats, and unexplained weight loss—are common to many forms of EPTB and should raise suspicion, especially in people with risk factors.

When to See a Doctor

Because EPTB can masquerade as many other diseases, prompt medical evaluation is essential when any of the following occur:

• Persistent, unexplained swelling of lymph nodes, especially in the neck.
• Chest pain or shortness of breath that does not improve with usual care.
• New, worsening headache, neck stiffness, or seizures.
• Joint pain or swelling that lasts longer than a few weeks without a clear injury.
• Unexplained fever, night sweats, or weight loss lasting >2 weeks.
• Changes in urinary patterns, blood in urine, or flank pain.
• Abdominal pain with persistent diarrhea or unexplained fluid buildup.
• Any of the above in someone who is HIV‑positive, has diabetes, or has recently started immunosuppressive medication.

Early assessment can prevent complications such as permanent neurological damage, severe joint destruction, or life‑threatening meningitis.

Diagnosis

Diagnosing EPTB requires a combination of clinical suspicion, imaging, laboratory tests, and, when possible, microbiologic confirmation.

1. Medical History & Physical Examination

The clinician will ask about travel, exposure to TB, HIV status, prior TB treatment, and symptoms. A focused exam looks for organ‑specific signs (e.g., lymphadenopathy, spinal tenderness, neurologic deficits).

2. Imaging Studies

• Chest X‑ray or CT scan – evaluates for concomitant pulmonary disease and pleural effusions.
• Ultrasound – useful for abdominal ascites, liver lesions, or enlarged lymph nodes.
• Magnetic Resonance Imaging (MRI) – the gold standard for spinal TB, tuberculomas, and meningitis.
• Bone scan or PET‑CT – can detect skeletal involvement when plain radiographs are nondiagnostic.

3. Laboratory Tests

• Tuberculin skin test (TST) or interferon‑γ release assays (IGRAs) – indicate a TB infection but cannot differentiate active from latent disease.
• Complete blood count (CBC) and inflammatory markers – often show anemia and elevated ESR/CRP.
• HIV testing – recommended for all patients with suspected TB.

4. Microbiologic Confirmation

Definitive diagnosis hinges on detecting M. tuberculosis in specimens from the affected site.

• Acid‑fast bacilli (AFB) smear – quick but less sensitive for extrapulmonary samples.
• Culture (solid or liquid media) – gold standard; results may take 2–6 weeks.
• Polymerase chain reaction (PCR) / GeneXpert MTB/RIF – rapid (hours) and can detect rifampin resistance.
• Histopathology – tissue biopsy often shows caseating granulomas, supporting the diagnosis when cultures are negative.

5. Special Tests for Specific Sites

• Lumbar puncture for suspected TB meningitis – CSF typically shows lymphocytic pleocytosis, low glucose, and elevated protein.
• Urine AFB or PCR for genitourinary TB.
• Fine‑needle aspiration (FNA) or excisional biopsy of enlarged lymph nodes.

Because culture may be negative in up to 30 % of EPTB cases, clinicians often combine clinical, radiologic, and histologic clues to start therapy promptly.

Treatment Options

Standard anti‑TB therapy is effective for most forms of EPTB, but duration and adjunctive measures vary by site.

1. First‑Line Anti‑TB Regimen

According to the World Health Organization (WHO) and CDC guidelines, the typical 6‑month regimen includes:

• Intensive phase (2 months): Isoniazid (H), Rifampin (R), Pyrazinamide (Z), and Ethambutol (E) – often abbreviated as HRZE.
• Continuation phase (4 months): Isoniazid + Rifampin (HR).

Doses are weight‑based and must be taken under directly observed therapy (DOT) when possible to ensure adherence.

2. Extended or Modified Regimens

• TB meningitis, bone & joint disease, or disseminated TB – treatment is usually extended to 9–12 months.
• Drug‑resistant TB (MDR/XDR) – requires second‑line agents such as fluoroquinolones, linezolid, bedaquiline, or delamanid, guided by susceptibility testing.

3. Adjunctive Therapies

• Corticosteroids – recommended for TB meningitis, pericardial TB, and severe pleural effusions to reduce inflammation and improve outcomes.<sup>2</sup>
• Surgical intervention – may be necessary for abscess drainage, debridement of bone lesions, or relieving spinal cord compression.
• Physical therapy – essential for restoring joint mobility after skeletal TB.

4. Home Care & Supportive Measures

• Take medication exactly as prescribed; never stop early, even if symptoms improve.
• Maintain a balanced diet rich in protein, vitamins A, D, and C to support immune recovery.
• Stay hydrated; treat fevers with acetaminophen (avoid NSAIDs if there is liver involvement).
• Use insect‑proof bedding if living in a TB‑endemic area to limit transmission.
• Attend all follow‑up appointments for blood tests (liver function, renal function) and imaging.

Prevention Tips

While it is impossible to eliminate all TB exposure, several practical steps can lower the risk of developing EPTB:

• Vaccination – Bacillus Calmette‑Guérin (BCG) vaccine offers protection against severe forms of TB, especially TB meningitis and disseminated disease in children.
• Screen high‑risk populations – routine TST/IGRA testing for people with HIV, diabetes, or those on TNF‑inhibitors.
• Prompt treatment of latent TB infection (LTBI) – 3‑month weekly isoniazid‑rifapentine (3HP) or 4‑month daily rifampin regimens are effective.
• Infection control in healthcare settings – use of N95 respirators, negative‑pressure rooms, and UV germicidal irradiation.
• Adherence to a full course of therapy if you have active pulmonary TB; this reduces bacterial load and the chance of spread.
• Healthy lifestyle – adequate nutrition, regular exercise, and smoking cessation improve immune competence.
• Travel precautions – avoid close, prolonged contact with individuals known to have active TB in high‑burden regions.

Emergency Warning Signs

---

Sources:
1. World Health Organization. Global tuberculosis report 2023.
2. British Medical Journal. “Adjunctive corticosteroid therapy for tuberculous meningitis.” 2022; 378: e069596.
3. Centers for Disease Control and Prevention. “Extrapulmonary Tuberculosis.” Updated 2024.
4. Mayo Clinic. “Tuberculosis (TB) – Symptoms and causes.” Accessed June 2026.
5. Cleveland Clinic. “Treatment of Tuberculosis.” Accessed June 2026.

```